CD200 and Parkinson disease: These results indicate that both CD200-CD200R1 and CX3CL1-CX3CR1 are involved in the checkpoint mechanisms regulating microglial phenotypes in the early stage of PD and that CD200-CD200R1 signaling is more sensitive.